ClinicalTrials.Veeva

Menu

Development of a Prediction Model for Differential Diagnosis Between Intestinal Tuberculosis and Crohn's Disease

A

Asan Medical Center

Status

Completed

Conditions

Intestinal Tuberculosis
Crohn's Disease

Study type

Observational

Funder types

Other

Identifiers

NCT01392365
2011-0380

Details and patient eligibility

About

The aim of this study is to develop a scoring system and a prediction model for differential diagnosis between intestinal tuberculosis and Crohn's disease.

Full description

Crohn's disease and intestinal tuberculosis mimic each other in clinical, endoscopic, and histological features. In addition, the yield of microbiological/histological test (AFB stain, caseating granuloma) is not high in clinical setting. Therefore, distinguishing CD from ITB especially in highly endemic areas for TB is challenging. The aim of this study is to develop and to validate a scoring system and a prediction model for differential diagnosis between intestinal tuberculosis and Crohn's disease

Enrollment

117 patients

Sex

All

Ages

16+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Final diagnostic criteria:

  • Crohn' disease (at least two of the following is met)

    1. Clinical history of abdominal pain, weight loss, malaise, diarrhea, and/or rectal bleeding
    2. Endoscopic findings of mucosal cobblestoning, linear ulceration, skip areas, or perianal disease
    3. Radiologic findings of stricture, fistula, mucosal cobblestoning, or ulceration
    4. Macroscopic appearance of bowel-wall induration, mesenteric lymphadenopathy, and "creeping fat" at laparotomy
    5. Pathologic findings of transmural inflammation and/or epithelioid granulomas
  • Intestinal tuberculosis(at least one of the following is met)

    1. Histologic evidence of caseating granulomas
    2. Histologic demonstration of acid-fast bacilli
    3. Growth of M. tuberculosis on tissue culture
    4. Clinical, colonoscopic, radiologic, and/or operative evidence of Intestinal tuberculosis with proved tuberculosis elsewhere
    5. Response to antituberculous therapy without subsequent recurrence in patients with clinical, colonoscopic, radiologic, and/or operative evidence of Intestinal tuberculosis

Exclusion Criteria:

  • Refusal to participate in the study
  • Age: 15 years or younger
  • Comorbidity with acute infectious disease
  • Pregnancy
  • Previous history of medication including anti-TB drugs, immunosuppressive drugs, and chemotherapeutic agents\
  • Use of antibiotics within the previous three months

Trial design

117 participants in 2 patient groups

Crohn' disease
Description:
The group of patients whose final diagnosis is Crohn's disease
Intestinal tuberculosis
Description:
The group of patients whose final diagnosis is intestinal tuberculosis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems